- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-666/24 R: Order of the President of the General Court of 27 March 2025 – Teva Pharma v EMA (Interim relief – Access to documents – Regulation (EC) No 1049/2001 – Documents relating to the EMA’s scientific advice given pursuant to Article 57(1)(n) of Regulation (EC) No 726/2004 – Decision to grant a third party access to the documents – Application for suspension of operation of a measure – No urgency)
ECLI:EU:UNKNOWN:62024TB0666
62024TB0666
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C series
—
C/2025/2557
12.5.2025
(Case T-666/24 R)
(Interim relief - Access to documents - Regulation (EC) No 1049/2001 - Documents relating to the EMA’s scientific advice given pursuant to Article 57(1)(n) of Regulation (EC) No 726/2004 - Decision to grant a third party access to the documents - Application for suspension of operation of a measure - No urgency)
(C/2025/2557)
Language of the case: English
Parties
Applicant: Teva Pharma BV (Haarlem, Netherlands) (represented by: C. Lindenthal and A. Säurig, lawyers)
Defendant: European Medicines Agency (represented by: G. Gavriilidou, S. Drosos and G. Ramo, acting as Agents)
Re:
By its application based on Articles 278 and 279 TFEU, the applicant seeks suspension of the operation of Decision EMA/391476/2024 Rev.1 of the European Medicines Agency (EMA) of 28 October 2024 granting a third party, under Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43), access to a document relating to scientific advice concerning the medicinal product ferric carboxymaltose, subject to certain redactions.
Operative part of the order
The application for interim measures is dismissed.
The order of 30 December 2024, Teva Pharma v EMA (T-666/24 R), is cancelled.
The costs are reserved.
—
ELI: http://data.europa.eu/eli/C/2025/2557/oj
ISSN 1977-091X (electronic edition)
—